Similarly, the levels of cytotoxicity-related markers, including GZMA, PFN1, GZMB, and GZMH, were significantly higher in CD8 CTL of patients with IgG4-RD than in HCs (Figure 5G). This evidence concerns the gene CD8A and immunoglobulin G4-related sclerosing disease.